DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZMYND8 |
19.9% Increase DNA Methylation |
|
DAA2447 |
protein kinase N1 isoform 2 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PKN1 |
27.7% Increase DNA Methylation |
|
DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|
DAA2448 |
semaphorin 3B isoform 2 precursor increases with age |
Molecular |
mesenchymal stem cell |
Human |
SEMA3B |
19.1% Increase DNA Methylation |
|
DAA2451 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SERPINA12 |
52.7% Increase DNA Methylation |
|
DAA2432 |
sperm associated antigen 7 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SPAG7 |
26.2% Decrease DNA Methylation |
|
DAA2438 |
syncoilin; intermediate filament 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SYNC |
21.4% Increase DNA Methylation |
|
DAA2459 |
transmembrane 4 superfamily member 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TSPAN8 |
36.4% Increase DNA Methylation |
|
DAA2457 |
tumor necrosis factor receptor superfamily; member 17 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TNFRSF17 |
18.8% Increase DNA Methylation |
|
DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
WISP2 |
23.5% Decrease DNA Methylation |
|
DAA2435 |
zinc finger protein 549 increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZNF549 |
19.3% Increase DNA Methylation |
|
DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
15.1% Decrease DNA Methylation |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA2442 |
ATP-binding cassette; sub-family A member 8 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
ABCA8 |
25.0% Decrease DNA Methylation |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2461 |
calcyphosine isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPS |
17.3% Decrease DNA Methylation |
|
DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2450 |
casein kappa increases with age |
Molecular |
mesenchymal stem cell |
Human |
CSN3 |
16.3% Increase DNA Methylation |
|
DAA2455 |
CD34 antigen isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CD34 |
17.3% Decrease DNA Methylation |
|
DAA2454 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
CCR1 |
31.2% Increase DNA Methylation |
|
DAA2441 |
complement factor D preproprotein increases with age |
Molecular |
mesenchymal stem cell |
Human |
CFD |
22.2% Increase DNA Methylation |
|
DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CDKN2B |
16.7% Decrease DNA Methylation |
|
DAA2437 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
DHRS3 |
18.6% Decrease DNA Methylation |
|